Search results
Results from the WOW.Com Content Network
Prospective Registry Of MammaPrint in breast cancer patients with an Intermediate recurrence Score . This will be a prospective observational, case-only, study of MammaPrint in patients with an Oncotype DX intermediate score (18-30). The clinical data is to be entered online. There will be two Case Report Forms (CRF).
The Nottingham prognostic index (NPI) is used to determine prognosis following surgery for breast cancer. [1] [2] Its value is calculated using three pathological criteria: the size of the tumour; the number of involved lymph nodes; and the grade of the tumour. [1] It is calculated to select patients for adjuvant treatment.
A lifetime risk score of 7% means a woman's estimated risk of developing breast cancer through age 90 is 7%. Mammogram guidelines are for women at average risk, said Dr. Arif Kamal, chief patient ...
The site began in 1998 as a pen and paper questionnaire called the Harvard Cancer Risk Index. [2] In January 2000, The Harvard Cancer Risk Index developed into an online assessment and was renamed Your Cancer Risk, and offered assessments for four cancers: breast, colon, lung, and prostate. Six months later, eight additional cancers were added. [3]
The Breast Imaging-Reporting and Data System (BI-RADS) is a quality assurance tool originally designed for use with mammography.The system is a collaborative effort of many health groups but is published and trademarked by the American College of Radiology (ACR).
The NCCN Panel considers the 21-gene assay as an option when evaluating certain tumors [39] to assist in estimating likelihood of recurrence and benefit from chemotherapy, emphasizing that the recurrence score should be used along with other breast cancer classification elements when stratifying risk. [39]
The Ki-67 score closely correlates with other proliferation markers, and has been shown to have prognostic and predictive value for many different tumor types. [9] Similarly, proliferating cell nuclear antigen (PCNA) is a protein associated with cell proliferation that is upregulated in proliferating cells, making it another useful antigen for ...
A score of 1 is assigned to a benign test result, 2 applies to a suspicious test result, and 3 applies to a malignant result. The sum of the scores of all three procedures is the triple test score. If the total summed score from the three tests is 3 to 4 then the diagnosis is most likely benign. A total summed score of 5 is considered suspicious.